Kentaro Tajima

7PUBLICATIONS
21CO-AUTHORS
Disease surveillancePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 10, 2026
Burden of Respiratory Syncytial Virus in Older ADults in Nagasaki, Japan (Nagasaki ROAD): Preliminary Results (April 2024-March 2025) of a Prospective, Multicenter, Epidemiological Study.

Takahiro Takazono, Norihito Kaku, Naoki Hosogaya

|Jun 12, 2024
A descriptive analysis of real-world oncology biosimilar use in Japan.

Joshua A Roth, Makan Rahshenas, Grégoire Nowacki

|Apr 20, 2024
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.

Tetsuhiro Yoshinami, Shigenori E Nagai, Masaya Hattori

|May 22, 2023
Real-world treatment patterns of novel drugs in relapsed or refractory acute lymphoblastic leukemia patients in Japan.

Toyoki Moribe, Linghua Xu, Kentaro Tajima

|Jul 14, 2022
Development and validation of claims-based algorithms to identify pregnancy based on data from a university hospital in Japan.

Kentaro Tajima, Tomofumi Ishikawa, Aoi Noda

|Apr 23, 2022
Validity of Administrative Data for Identifying Birth-Related Outcomes with the End Date of Pregnancy in a Japanese University Hospital.

Kentaro Tajima, Tomofumi Ishikawa, Fumiko Matsuzaki

Pageof 2

Frequent Collaborators

3 joint publications

Tomofumi Ishikawa

3 joint publications

Taku Obara

2 joint publications

Fumiko Matsuzaki

1 joint publications

Masami Tsuchiya